GRIFFONIA
Food supplement declared in France, declaration No 2024-3-3, decision dated 1 March 2024
GRIFFONIA (MAJELIS) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 point in its composition requires a check (prohibited substance, dose or novel food).
- Brand
- MAJELIS
- Food business operator placing the product on the market
- SAS MAJELIS
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 2 gélules
- Directions for use
- 2 gélules par jour
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Femmes enceintes, Sous antidépresseurs
- Objectives stated by the manufacturer (these are not authorised claims)
- Système nerveux
Declaration 139611, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Substance interdite
Griffonia simplicifolia (DC.) Baill.: dangerous plant prohibited in food in Belgium (list 1).
Source: Belgium, Royal Decree of 31 August 2021, plant lists (annex replaced on 30 January 2024), arrêté royal du 31 août 2021, annexe remplacée le 30 janvier 2024, liste 1, page PDF 73.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Griffonia simplicifolia (DC.) Baill. | Graine | Extrait sec aqueux | 300 mg |
Additives
E464, E470b
Other ingredients
maltodextrine
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging
Label warnings
Déconseillé chez la femme enceinte ou allaitante, ainsi qu'aux personnes sous traitement antidépresseur.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.
Brand : MAJELIS